← SynDRA
LENIOLISIB
SynDRA canonical compound SYN0038357 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PIK3CD |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- PIK3CD
- PIK3CA
- PDE4D
- PIK3CB
- PIK3CG
- PRKDC
- Pik3cg
Mechanisms of action (all sources)
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PIK3CA INHIBITOR
- PI3K inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR2B
- ABL1
- MC3R
- OPRK1
- OPRD1
- NR3C1
- NR1I2
- NPY1R
- MTOR
- MLNR
- MKNK2
- MET
- MAPKAPK5
- JAK2
- MAPKAPK2
- MAPK14
- MAPK1
- MAP3K8
- MAOA
- LCK
- KIT
- KDR
- KCNH2
- OPRM1
- PDE3A
- PDGFRA
- RET
- TYK2
- TP53
- TBXA2R
- SYK
- SLC6A4
- SLC6A3
- SLC6A2
- RPS6KA5
- ROCK2
- PTGS2
- PDK1
- PRKCQ
- PRKCA
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Phosphoinositide-3 Kinase Inhibitors
ATC classes
Cross-references
Synonyms
- JOENJA
- Joenja
- leniolisib phosphate
- joenja
- CDZ173-NX
- CDZ-173
- CDZ173
- CDZ-173 FREE BASE
- CDZ173 FREE BASE
- CDZ-173-NX
- LENIOLISIB (CDZ 173)
- Leniolisib free base
- UNII-L22772Z9CP
- L22772Z9CP
- 1354690-24-6 (free base)
- leniolisib(CDZ 173)
- Leniolisib [INN]
- Leniolisib (CDZ173)
- Leniolisib (USAN/INN)
- SCHEMBL323054
- GTPL9424
- CHEMBL3643413
- BDBM118299
- EX-A2854
- MFCD30470232
- s8752
- ZB1510
- CS-7524
- DC22326
- SB18839
- Example 67 [WO2012004299]
- AS-56217
- HY-17635
- A16796
- D11158
- US8653092, 67
- Q27282602
- 9NQ
Look up LENIOLISIB in the interactive SynDRA portal →